November 14th is closing in, only 31 more days. With the last three months of reported revenues, the Q3 results will look as good as we are anticipating. Along with this, I would guess a cash flow positive position would be obvious. It has taken some time for everything to develop but the future of SCRC couldn't look better. In fact, I will go out on the limb and predict October approved orders will be another record breaking month leading to Q4 results being record breaking as well. I'm looking at October recording $5.7-5.8M. With PIMD, potential RapiMeds revenues, and the other revenue agreements Mr. Schneiderman has put in place, Q4 should exceed all expectations. Our patience will soon be rewarded.